Related Experiment Video
Updated: May 12, 2026

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
Published on: November 4, 2016
Blastic plasmacytoid dendritic cell neoplasm
David Lim1, Hugh Goodman, Marius Rademaker
1Department of Dermatology, Waikato Hospital, Hamilton, Waikato, New Zealand. davidlim79@gmail.com
Abstract:
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy that originates from the precursors of plasmacytoid dendritic cells. It commonly presents with findings isolated to the skin although it usually progresses to a leukaemic phase. It has a poor prognosis but is curable, particularly in younger patients treated with allogeneic bone marrow transplantation. We report a case of a 79-year old man who had 6 months of progressive, asymptomatic BPDCN manifestations limited to the skin, before developing a leukaemic phase.
Related Concept Videos
Abnormal Proliferation
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Cellular Adaptation IV: Dysplasia and Metaplasia
